|

Fenofibrate Clinical Trials

6 actively recruiting trials across 2 locations

Also known as: Antara, Fenoglide, Lipofen, Tricor, Triglide

Pipeline

Early 1: 1Phase 1: 1Phase 3: 3Phase 2/3: 1

Top Sponsors

  • Xijing Hospital of Digestive Diseases4
  • Lindsay Ferguson, MD1
  • Jaeb Center for Health Research1

Indications

  • Liver Disease4
  • Primary Biliary Cholangitis (PBC)3
  • Primary Biliary Cholangitis1
  • Diabetic Retinopathy1
  • Invasive Cervical Cancer1

Other4 trials

FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy
Phase 3
Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)
Phase 2/3
Fenofibrate in Primary Biliary Cholangitis: a Real World Study
Phase 3
Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)
Early 1

Glendale, California1 trial

Fenofibrate for Prevention of DR Worsening

Kent W. Small, MD, AMC

Phase 3

Cleveland, Ohio1 trial

Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.